tiprankstipranks
Health In Tech, Inc. Class A (HIT)
NASDAQ:HIT
US Market

Health In Tech, Inc. Class A (HIT) Earnings Dates, Call Summary & Reports

108 Followers

Earnings Data

Report Date
Apr 20, 2026
After Close (Confirmed)
Period Ending
2026 (Q1)
Consensus EPS Forecast
-0.03
Last Year’s EPS
0.02
Same Quarter Last Year
Moderate Buy
Based on 2 Analysts Ratings

Earnings Call Summary

Q4 2025
Earnings Call Date:Mar 25, 2026|
% Change Since:
|
Earnings Call Sentiment|Positive
The call conveyed strong growth and improving profitability at the full-year level (71% revenue growth, margin expansion, positive operating cash flow, distribution and enrollment expansion, and confident 2026 guidance). At the same time, the company flagged near-term timing and seasonality impacts (notably weaker Q4 profitability), and several strategic initiatives (large-employer product, three-year rate stabilization, physiological data beta) remain early-stage with long sales cycles and not yet material to revenue. Overall, the positives (rapid revenue growth, improving margins, cash generation, product/AI momentum and clear guidance) outweigh the near-term operational and timing headwinds.
Company Guidance
For 2026 management guided revenue of $45.0–$50.0 million, implying roughly 35%–50% year‑over‑year growth versus 2025 revenue of $33.3 million (Q4 2025 revenue $7.5M), supported by distribution scale (885 brokers/TPAs/agencies, +34% YoY), 22,515 enrolled employees (+23% YoY), and platform enhancements (100+ preconfigured stop‑loss programs launched Jan 2026 and features that can compress time‑to‑revenue to 1–2 quarters versus 12–24 months). They cited 2025 profitability and efficiency metrics backing the outlook: adjusted EBITDA $4.1M (12.3% of revenue, +81% YoY), net income $1.2M (~4%, +91% YoY), full‑year pre‑tax income $1.7M, positive operating cash flow $3.1M, AR days down to 14 from 29, $7.7M cash on hand, and total operating expenses of $19.4M (58% of revenue), while noting Q4 reinvestments that produced Q4 adjusted EBITDA $0.3M and a Q4 net loss of $0.3M.
Strong Full-Year Revenue Growth
Total revenue increased 71% year-over-year for full year 2025 to $33,300,000, reflecting broad adoption of the AI-enabled underwriting marketplace.
Robust Quarterly Performance
Fourth-quarter revenue grew 53% year-over-year to $7,500,000, demonstrating continued momentum despite seasonality and timing dynamics.
Improved Profitability and Operating Leverage (FY)
Full-year adjusted EBITDA was $4,100,000 (≈12.3% of revenue), up 81% year-over-year. GAAP net income was $1,200,000 (≈4% of revenue), up 91% year-over-year, indicating improving margins as the business scales.
Distribution and Enrollment Expansion
Distribution network expanded ~34% year-over-year to ~885 brokers, TPAs, and agency partners, and enrolled employees rose 23% year-over-year to 22,515, increasing the platform's quoting activity and conversion efficiency.
Platform Product-Market Progress — Upmarket Move
Expanded EDIBS to support employers with over 100 employees (up-market entry), and compressed large-employer underwriting timelines from ~3 months to roughly 2 weeks, improving broker productivity and placement efficiency.
Clear 2026 Revenue Guidance
Provided full-year 2026 revenue guidance of $45,000,000 to $50,000,000, implying approximately 35% to 50% year-over-year growth and signaling confidence in near-term scaling.
Healthy Cash Generation and Balance Sheet Actions
Generated $3,100,000 of positive operating cash flow for 2025, reduced accounts receivable days to 14 (from 29 in 2024), invested $3,200,000 in platform development, and ended the year with $7,700,000 in cash and cash equivalents.
Product and Platform Enhancements
Launched >100 preconfigured stop-loss programs (Jan 2026 enhancement), continuing AI investments, began beta of a physiological + claims data solution, and strengthened cloud/tech partnerships (Siclim/AWS) to support marketplace expansion.

Health In Tech, Inc. Class A (HIT) Earnings, Revenues Date & History

The upcoming earnings date is based on a company’s previous reporting, and may be updated when the actual date is announced

HIT Earnings History

Report Date
Fiscal Quarter
Forecast / EPS
Last Year's EPS
EPS YoY Change
Press Release
Slides
Play Transcript
Apr 20, 2026
2026 (Q1)
-0.03 / -
0.015
Mar 25, 2026
2025 (Q4)
-0.01 / -0.01
-0.010.00% (0.00)
Nov 10, 2025
2025 (Q3)
0.01 / 0.01
0.00742.86% (<+0.01)
Jul 21, 2025
2025 (Q2)
0.01 / 0.01
0.00666.67% (<+0.01)
Apr 14, 2025
2025 (Q1)
0.01 / 0.01
0.002650.00% (+0.01)
Mar 17, 2025
2024 (Q4)
- / -0.01
0.018-155.56% (-0.03)
The table shows recent earnings report dates and whether the forecast was beat or missed. See the change in forecast and EPS from the previous year.
Beat
Missed

HIT Earnings-Related Price Changes

Report Date
Price 1 Day Before
Price 1 Day After
Percentage Change
Mar 25, 2026
$1.81$1.61-11.05%
Nov 10, 2025
$2.92$2.15-26.37%
Jul 21, 2025
$1.35$1.69+25.19%
Apr 14, 2025
$0.69$0.70+1.45%
Earnings announcements can affect a stock’s price. This table shows the stock's price the day before and the day after recent earnings reports, including the percentage change.

FAQ

When does Health In Tech, Inc. Class A (HIT) report earnings?
Health In Tech, Inc. Class A (HIT) is schdueled to report earning on Apr 20, 2026, After Close (Confirmed).
    What is Health In Tech, Inc. Class A (HIT) earnings time?
    Health In Tech, Inc. Class A (HIT) earnings time is at Apr 20, 2026, After Close (Confirmed).
      Where can I see when companies are reporting earnings?
      You can see which companies are reporting today on our designated earnings calendar.
        What companies are reporting earnings today?
        You can see a list of the companies which are reporting today on TipRanks earnings calendar.
          What is HIT EPS forecast?
          HIT EPS forecast for the fiscal quarter 2026 (Q1) is -0.03.